Evidence map›Paper›PMID 40980312›Full record

SynthesisFrontiers in microbiology2025

The metabolic endotoxemia and gut microbiota: research trajectories and hot trends across the centuries (1999-2024).

Enlin Jian, Mengping Wang, Zhen Zhang, Yiwei Heng, Chengwei Zhang, Qing Chen, Xiaoping Yu, Yanfeng Zhu, Peiling Cai

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Peptide Hormones in Appetite Regulation: A Complex Network.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  7. Review
  8. Foods (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Foods (Basel, Switzerland) · 2026
    Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Enlin Jian *School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.
Mengping Wang *School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.
Zhen Zhang *School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.
Yiwei HengClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Chengwei ZhangClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Qing ChenSchool of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.
Xiaoping YuSchool of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.
Yanfeng ZhuSchool of Public Health, Chengdu Medical College, Chengdu, Sichuan, China.
Peiling CaiSchool of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metabolic endotoxemia, characterized by chronic low-grade elevation of circulating bacterial endotoxins such as lipopolysaccharides derived from Gram-negative bacteria, has emerged as a central focus in metabolic disease research. Notably, emerging evidence highlights the pivotal role of gut microbiota in driving this condition, though critical knowledge gaps persist regarding the precise mechanisms mediated by gut microbiota-derived metabolites and their specific signaling pathways, as well as the development of individualized intervention strategies. To systematically map the evolving research landscape, this review employs bibliometric analysis to identify emerging trends and patterns in understanding the interplay between metabolic endotoxemia and gut microbial communities. Materials and methods: This study employed a comprehensive bibliometric analysis of scholarly literature indexed in the Web of Science Core Collection (1900-2024) to investigate research patterns in metabolic endotoxemia and gut microbiota. Through multidimensional examination using VOSviewer, CiteSpace, the bibliometrix R package, and the online bibliometric analysis platform (https://bibliometric.com/), we systematically mapped research priorities, collaborative networks, and evolving frontiers in this interdisciplinary field. The methodology incorporated advanced visualization techniques and quantitative assessments to identify thematic clusters, institutional contributions, and knowledge diffusion pathways within the extant literature corpus. Results: This comprehensive global analysis, encompassing 1,585 relevant studies, demonstrates compelling evidence that China and USA collectively contribute over 50% of scientific output in this specialized research domain. Notably, academic investigations into metabolic endotoxemia and gut microbiota continue to maintain substantial research momentum. Current scholarly discourse prominently features five key thematic clusters: gut dysbiosis, intestinal barrier, risk, gut-liver axis, and short-chain fatty acids. Conclusion: This in-depth review systematically examines the evolving research landscape and emerging investigative priorities in metabolic endotoxemia and gut microbiota. It equips researchers with a comprehensive overview of key contributors in these specialized fields, including leading nations, institutions, academic journals, and potential collaborative networks. The analysis further delineates cutting-edge research frontiers and proposes strategic directions for future investigation, thereby serving as an invaluable resource for scholars navigating the complex interplay between metabolic endotoxemia and gut microbiota in the intestinal ecosystem.

Indexed as

bibliometric analysisgut microbiotahotspotsmetabolic endotoxemiaresearch trend

Identifiers

PMID40980312
PMCPMC12446963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.